DAVID OSUJI: Open Payments
NPI 1558011643 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,481 in 212 payments from 18 companies in 2025. Trend: 2023 $1,033 · 2024 $2,306 · 2025 $3,481
Food & beverage: $3,481
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 25 | $592 |
| Alkermes, Inc. | 19 | $412 |
| Teva Pharmaceuticals USA, Inc. | 36 | $399 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $384 |
| Otsuka America Pharmaceutical, Inc. | 22 | $291 |
| Vanda Pharmaceuticals Inc. | 19 | $270 |
| Neurocrine BioSciences, Inc. | 9 | $233 |
| Lundbeck LLC | 14 | $214 |
| ABBVIE INC. | 13 | $158 |
| Indivior Inc. | 11 | $155 |
Products named: COBENFY, REXULTI, CAPLYTA, FANAPT, UZEDY, INGREZZA, ARISTADA, LYBALVI.
Industry payments across TX — which companies pay providers there.
